Table 4 Subgroup analysis for pooled prevalence of CD in Asian-Pacific region among at-risk and not at-risk populations.
Sero-prevalence in not at-risk population | Biopsy-confirmed prevalence in not at-risk population | Biopsy-confirmed prevalence in at-risk population | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
N. patients | N. subjects | Pooled prevalence | P-value | N. patients | N. subjects | Pooled prevalence | P-value | N. patients | N. subjects | Pooled prevalence | P-value | |
Population | ||||||||||||
Adult | 310 | 56,707 | 1.01% | 0.01 | 170 | 26,738 | 0.55% | 0.02 | 80 | 2282 | 3.13% | 0.08 |
Children | 664 | 28,904 | 2.01% | 193 | 33,118 | 0.66% | 308 | 6396 | 5.28% | |||
Adults and children | 151 | 10,488 | 1.44% | 109 | 10,488 | 1.04% | 97 | 1454 | 4.71% | |||
Sex | ||||||||||||
Male | 394 | 45,074 | 0.8% | 0.04 | 163 | 30,345 | 0.53% | 0.04 | 244 | 4384 | 4.02% | 0.43 |
Female | 543 | 37,597 | 1.65% | 182 | 23,592 | 0.74% | 183 | 5021 | 4.82% | |||
Region | ||||||||||||
Oceania | – | – | – | < 0.001 | 20 | 4075 | 0.61% | < 0.001 | 187 | 4434 | 4.22% | < 0.001 |
Middle East | 647 | 31,452 | 1.47% | 215 | 38,538 | 0.59% | 233 | 5226 | 4.07% | |||
South Asia | 467 | 44,869 | 1.25% | 236 | 25,723 | 0.87% | 49 | 723 | 7.10% | |||
East Asia | 11 | 19,778 | 0.06% | 1 | 2008 | 0.05% | 16 | 337 | 3.65% | |||
Risk of CD | ||||||||||||
DS | – | – | – | – | – | – | – | 10 | 306 | 2.90% | 0.05 | |
DM1 | – | – | – | – | – | – | – | 274 | 6145 | 5.06% | ||
Chronic diarrhea | – | – | – | – | – | – | – | 68 | 943 | 8.43% | ||
ATD | – | – | – | – | – | – | – | 15 | 691 | 2.94% | ||
Dyspeptic | – | – | – | – | – | – | – | 10 | 407 | 2.46% | ||
FDR | – | – | – | – | – | – | – | 49 | 1009 | 4.85% | ||
IBD | – | – | – | – | – | – | – | 58 | 1172 | 2.62% | ||
Abdominal pain | – | – | – | – | – | – | – | 1 | 47 | 2.13% | ||
